Cite
HARVARD Citation
Suzuki, T. et al. (2022). KRAS variant allele frequency, but not mutation positivity, associates with survival of patients with pancreatic cancer. Cancer science. 113 (9), pp. 3097-3109. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Suzuki, T. et al. (2022). KRAS variant allele frequency, but not mutation positivity, associates with survival of patients with pancreatic cancer. Cancer science. 113 (9), pp. 3097-3109. [Online].